Palladium is a global leader in the design, development and delivery of Positive Impact - the intentional creation of enduring social and economic value. We work with foundations, investors, governments, corporations, communities and civil society to formulate strategies and implement solutions that generate lasting social, environmental and financial benefits.
For the past 50 years, we have been making Positive Impact possible. With a team of more than 2,500 employees operating in 90 plus countries and a global network of more than 35,000 technical experts, Palladium has improved - and is committed to continuing to improve - economies, societies and most importantly, people’s lives.
Palladium is a child-safe organisation, and screens applicants for suitability to work with children. We also provide equal employment to all participants and employees without regard to race, color, religion, gender, age, disability, sexual orientation, veteran or marital status.
The Jordan Health Finance and Governance (HFG) is an activity funded by the United States Agency for International Development (USAID). It aims to improve health sector sustainability and resiliency in Jordan. HFG’s goal supports Jordan’s commitment to universal health coverage declared in the Jordan National Health Strategy 2016-2020 “…to provide health, financial, and social protection to the entire population on a fair basis.” HFG’s two primary objectives in support of the GOJ’s UHC goal are to promote: (1) Increased spending efficiency of public resources for health to ensure long term sustainability; and (2) Strengthened governance of the health sector at both national and subnational levels to more effectively coordinate, plan, manage, and monitor the health system.
Various assessments have found that the Government of Jordan would benefit from an enhanced procurement and regulatory framework to ensure long-term access to more affordable vaccine prices and vaccine security, limiting the sustainability of Jordan’s vaccine program and resulting in higher annual vaccine costs and diminished fiscal space to introduce new vaccines in the future. Modification to the Government’s procurement, regulatory, budget and planning laws, policies, and processes could generate additional cost savings and efficiencies, allowing the Government to sustain financing for immunization and introduce new vaccines.
A Conditional Precedence (CP) to improve the efficiency and effectiveness in vaccine planning and procurement was submitted to the government of Jordan. As per the CP, the Government of Jordan needs to convene a high-level committee with representation from the Ministry of Health (MOH), Jordan Food and Drug Administration (JFDA), Joint Procurement Department (JPD), USAID, and UNICEF (and other relevant stakeholders) to analyze and identify necessary reforms to modernize the Government of Jordan’s vaccine procurement laws, policies, and processes to build a more sustainable and cost-effective vaccine program. The CP will be met when the MOH submits a complete analysis and action plan with a detailed timeline for implementing vaccine procurement reforms, for review and agreement by USAID Jordan.
Realizing the fact that the pharmaceutical procurement system is a major determinant of pharmaceutical availability and total pharmaceutical costs. USAID’s Health Financing and Governance Activity (HFG) is currently engaged with related GOJ stakeholders including the Joint Procurement department (JPD) and the Procurement and Supplies Directorate (PSD) at Ministry of Health (MOH) to introduce key principles and best practices for pharmaceutical procurement, develop forecasting tools for pharmaceutical needs and assist in the implementation of developed procurement mechanisms, and ensuring compliance with its regulation.
On the other hand and to specifically support improved efficiency and effectiveness in vaccine planning and procurement, HFG initiated the work on an external analysis of existing vaccine procurement and regulatory laws, policies, and processes to determine potential areas for enhancing the efficiency and effectiveness of the vaccines procurement process. This will feed in validating the initial findings regarding potential mitigation solutions that could help to achieve cost-savings and reduced prices for vaccines, and will inform the work of the National Vaccines Procurement Modernization Committee.
In alignment with these efforts, HFG will be providing technical assistance to the formulated National Vaccine Procurement Modernization Committee to complete analysis and develop action plan with a detailed timeline for implementing vaccine procurement reforms. The action plan should outline findings, identifies laws, policies, and processes that could be amended to address necessary reforms to vaccine planning and procurement, and determines an actionable timeline with responsible parties. HFG is seeking to hire an expert in pharmaceutical/vaccine procurement to provide technical expertise with the following qualifications:
- Advanced degree in business management, international studies or related fields with training in international procurement and supply chain management
- Demonstrated knowledge and working experience in of Pharmaceutical/Vaccines procurement standards and practices
- Hands on experience in vaccine procurement
- Previous working experience with government entities, in the health sector
- Training experience and skills
- Strong leadership and time management skills
- Proficiency in Arabic and English , both written and Oral